Patents by Inventor Benjamin BOYERINAS

Benjamin BOYERINAS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TGFBETA SIGNAL CONVERTOR
    Publication number: 20230364141
    Abstract: The present disclosure provides improved compositions for adoptive T cell therapies for treating, preventing, or ameliorating at least one symptom of a cancer, infectious disease, autoimmune disease, inflammatory disease, and immunodeficiency, or condition associated therewith.
    Type: Application
    Filed: April 7, 2023
    Publication date: November 16, 2023
    Inventor: Benjamin BOYERINAS
  • ENGINEERED T CELLS
    Publication number: 20230044580
    Abstract: The present disclosure provides improved compositions for adoptive T cell therapies for treating, preventing, or ameliorating at least one symptom of a cancer, infectious disease, autoimmune disease, inflammatory disease, and immunodeficiency, or condition associated therewith.
    Type: Application
    Filed: May 7, 2020
    Publication date: February 9, 2023
    Applicants: 2SEVENTY BIO, INC., MEDIGENE IMMUNOTHERAPIES GMBH
    Inventors: JASDEEP MANN, CHRISTIAN ELLINGER, DANIEL SOMMERMEYER, BENJAMIN BOYERINAS
  • TGFBeta SIGNAL CONVERTOR
    Publication number: 20190350974
    Abstract: The present disclosure provides improved compositions for adoptive T cell therapies for treating, preventing, or ameliorating at least one symptom of a cancer, infectious disease, autoimmune disease, inflammatory disease, and immunodeficiency, or condition associated therewith.
    Type: Application
    Filed: November 17, 2017
    Publication date: November 21, 2019
    Applicant: bluebird bio, Inc.
    Inventor: Benjamin BOYERINAS